T-cell receptor/CD28-targeted immunotherapeutics selectively drive naive T-cell expansion to generate functional HIV-specific responses. - Mueller AL; Lamcaj S; Garforth S; Hiner C; Woodley D; Paraiso K; Mi T; Low S; Youngblood B; Almo SC; Goldstein H (Journal of virology, 2025)